ABBV-838 is an antibody drug conjugate (ADC) targeting CS1 that is being investigated to treat multiple myeloma.

Type of Molecule

Biologic

Target

CS1

Region

n/a

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Multiple Myeloma (MM) New Indication Phase 1